Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma
Read more: Naoko Ronquest Ned Spencer #HealthPolicy #MarketAccess #HEOR #DrugPricing #HTA #ICER To view or add a comment, sign in What the Hell Happened This Week in Pharma
The landscape continues to evolve
Tirzepatide to retatrutide The tirzepatide to retatrutide transition requires extra caution because retatrutide adds glucagon receptor activation
The published evidence on Aerolase NeoElit specifically is thinner than for older Nd:YAG platforms, but the underlying physics is well-established
Available under notable brand names such as Wegovy for weight management and Ozempic for type 2 diabetes, semaglutide also includes an oral version to cater to preferences against injections
